Effects of Encaleret (CLTX-305) on Mineral Physiology in Autosomal Dominant Hypocalcemia Type 1 Demonstrate Proof-of-Concept: Early Results from a Phase 2B, Open-Label, Dose-Ranging Study [NCT04581629]

Saved in:
Bibliographic Details
Published in:Bone Reports 2022-05, Vol.16, p.101558, Article 101558
Main Authors: Gafni, Rachel, Hartley, Iris, Roszko, Kelly, Nemeth, Edward, Pozo, Karen, Sani-Grosso, Ramei, Mathew, Arun, Sridhar, Ananth, Roberts, Mary Scott, Fox, Jonathan, Collins, Michael
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 101558
container_title Bone Reports
container_volume 16
creator Gafni, Rachel
Hartley, Iris
Roszko, Kelly
Nemeth, Edward
Pozo, Karen
Sani-Grosso, Ramei
Mathew, Arun
Sridhar, Ananth
Roberts, Mary Scott
Fox, Jonathan
Collins, Michael
description
doi_str_mv 10.1016/j.bonr.2022.101558
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_bonr_2022_101558</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2352187222003928</els_id><sourcerecordid>S2352187222003928</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1408-46538e7e8578afef291a6b203c3c2bceefe2e1e0d53bc981f74e5dfb98a6f2553</originalsourceid><addsrcrecordid>eNp9UV-L1DAQL6Lgcd4X8GkeFa5rkjZtKr6cvb07YfWOcwVBJKTpZM3SJiXpCv2IfqvLsj74JAzMMMzvD_PLsteUrCih1bv9qvMurBhh7LjgXDzLzljBWU5FzZ7_M7_MLmLcE5KOmrJumrPsz9oY1HMEb2DttBow4Axv2s32e14Q_ha8g8_WYVADPPxaovWD3y1gHVwdZh_9mPbXfrROuRnulsknCo2jVbBdJgQK1zh6F-egZoSH4L3JU7XeaZzm97BWYVjgEeNhSB5M8COopKMiAvt4CfcTunyjOhwuk0rE_FG5nXU7-Dof-gV-fGm3pOSCVqz5-Sp7YdQQ8eJvP8--3ay37V2-ub_91F5tck1LIvKy4oXAGgWvhTJoWENV1TFS6EKzTiMaZEiR9LzodCOoqUvkvekaoSrDOC_OM3bi1cHHGNDIKdhRhUVSIo95yL085iGPechTHgn04QTC5Oy3xSCjtpie0NuQ3i97b_8HfwLI_ZOn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effects of Encaleret (CLTX-305) on Mineral Physiology in Autosomal Dominant Hypocalcemia Type 1 Demonstrate Proof-of-Concept: Early Results from a Phase 2B, Open-Label, Dose-Ranging Study [NCT04581629]</title><source>PMC (PubMed Central)</source><source>ScienceDirect Journals</source><creator>Gafni, Rachel ; Hartley, Iris ; Roszko, Kelly ; Nemeth, Edward ; Pozo, Karen ; Sani-Grosso, Ramei ; Mathew, Arun ; Sridhar, Ananth ; Roberts, Mary Scott ; Fox, Jonathan ; Collins, Michael</creator><creatorcontrib>Gafni, Rachel ; Hartley, Iris ; Roszko, Kelly ; Nemeth, Edward ; Pozo, Karen ; Sani-Grosso, Ramei ; Mathew, Arun ; Sridhar, Ananth ; Roberts, Mary Scott ; Fox, Jonathan ; Collins, Michael</creatorcontrib><identifier>ISSN: 2352-1872</identifier><identifier>EISSN: 2352-1872</identifier><identifier>DOI: 10.1016/j.bonr.2022.101558</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Bone Reports, 2022-05, Vol.16, p.101558, Article 101558</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2352187222003928$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3547,27923,27924,45779</link.rule.ids></links><search><creatorcontrib>Gafni, Rachel</creatorcontrib><creatorcontrib>Hartley, Iris</creatorcontrib><creatorcontrib>Roszko, Kelly</creatorcontrib><creatorcontrib>Nemeth, Edward</creatorcontrib><creatorcontrib>Pozo, Karen</creatorcontrib><creatorcontrib>Sani-Grosso, Ramei</creatorcontrib><creatorcontrib>Mathew, Arun</creatorcontrib><creatorcontrib>Sridhar, Ananth</creatorcontrib><creatorcontrib>Roberts, Mary Scott</creatorcontrib><creatorcontrib>Fox, Jonathan</creatorcontrib><creatorcontrib>Collins, Michael</creatorcontrib><title>Effects of Encaleret (CLTX-305) on Mineral Physiology in Autosomal Dominant Hypocalcemia Type 1 Demonstrate Proof-of-Concept: Early Results from a Phase 2B, Open-Label, Dose-Ranging Study [NCT04581629]</title><title>Bone Reports</title><issn>2352-1872</issn><issn>2352-1872</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9UV-L1DAQL6Lgcd4X8GkeFa5rkjZtKr6cvb07YfWOcwVBJKTpZM3SJiXpCv2IfqvLsj74JAzMMMzvD_PLsteUrCih1bv9qvMurBhh7LjgXDzLzljBWU5FzZ7_M7_MLmLcE5KOmrJumrPsz9oY1HMEb2DttBow4Axv2s32e14Q_ha8g8_WYVADPPxaovWD3y1gHVwdZh_9mPbXfrROuRnulsknCo2jVbBdJgQK1zh6F-egZoSH4L3JU7XeaZzm97BWYVjgEeNhSB5M8COopKMiAvt4CfcTunyjOhwuk0rE_FG5nXU7-Dof-gV-fGm3pOSCVqz5-Sp7YdQQ8eJvP8--3ay37V2-ub_91F5tck1LIvKy4oXAGgWvhTJoWENV1TFS6EKzTiMaZEiR9LzodCOoqUvkvekaoSrDOC_OM3bi1cHHGNDIKdhRhUVSIo95yL085iGPechTHgn04QTC5Oy3xSCjtpie0NuQ3i97b_8HfwLI_ZOn</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Gafni, Rachel</creator><creator>Hartley, Iris</creator><creator>Roszko, Kelly</creator><creator>Nemeth, Edward</creator><creator>Pozo, Karen</creator><creator>Sani-Grosso, Ramei</creator><creator>Mathew, Arun</creator><creator>Sridhar, Ananth</creator><creator>Roberts, Mary Scott</creator><creator>Fox, Jonathan</creator><creator>Collins, Michael</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202205</creationdate><title>Effects of Encaleret (CLTX-305) on Mineral Physiology in Autosomal Dominant Hypocalcemia Type 1 Demonstrate Proof-of-Concept: Early Results from a Phase 2B, Open-Label, Dose-Ranging Study [NCT04581629]</title><author>Gafni, Rachel ; Hartley, Iris ; Roszko, Kelly ; Nemeth, Edward ; Pozo, Karen ; Sani-Grosso, Ramei ; Mathew, Arun ; Sridhar, Ananth ; Roberts, Mary Scott ; Fox, Jonathan ; Collins, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1408-46538e7e8578afef291a6b203c3c2bceefe2e1e0d53bc981f74e5dfb98a6f2553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gafni, Rachel</creatorcontrib><creatorcontrib>Hartley, Iris</creatorcontrib><creatorcontrib>Roszko, Kelly</creatorcontrib><creatorcontrib>Nemeth, Edward</creatorcontrib><creatorcontrib>Pozo, Karen</creatorcontrib><creatorcontrib>Sani-Grosso, Ramei</creatorcontrib><creatorcontrib>Mathew, Arun</creatorcontrib><creatorcontrib>Sridhar, Ananth</creatorcontrib><creatorcontrib>Roberts, Mary Scott</creatorcontrib><creatorcontrib>Fox, Jonathan</creatorcontrib><creatorcontrib>Collins, Michael</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Bone Reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gafni, Rachel</au><au>Hartley, Iris</au><au>Roszko, Kelly</au><au>Nemeth, Edward</au><au>Pozo, Karen</au><au>Sani-Grosso, Ramei</au><au>Mathew, Arun</au><au>Sridhar, Ananth</au><au>Roberts, Mary Scott</au><au>Fox, Jonathan</au><au>Collins, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Encaleret (CLTX-305) on Mineral Physiology in Autosomal Dominant Hypocalcemia Type 1 Demonstrate Proof-of-Concept: Early Results from a Phase 2B, Open-Label, Dose-Ranging Study [NCT04581629]</atitle><jtitle>Bone Reports</jtitle><date>2022-05</date><risdate>2022</risdate><volume>16</volume><spage>101558</spage><pages>101558-</pages><artnum>101558</artnum><issn>2352-1872</issn><eissn>2352-1872</eissn><pub>Elsevier Inc</pub><doi>10.1016/j.bonr.2022.101558</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2352-1872
ispartof Bone Reports, 2022-05, Vol.16, p.101558, Article 101558
issn 2352-1872
2352-1872
language eng
recordid cdi_crossref_primary_10_1016_j_bonr_2022_101558
source PMC (PubMed Central); ScienceDirect Journals
title Effects of Encaleret (CLTX-305) on Mineral Physiology in Autosomal Dominant Hypocalcemia Type 1 Demonstrate Proof-of-Concept: Early Results from a Phase 2B, Open-Label, Dose-Ranging Study [NCT04581629]
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T05%3A14%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Encaleret%20(CLTX-305)%20on%20Mineral%20Physiology%20in%20Autosomal%20Dominant%20Hypocalcemia%20Type%201%20Demonstrate%20Proof-of-Concept:%20Early%20Results%20from%20a%20Phase%202B,%20Open-Label,%20Dose-Ranging%20Study%20%5BNCT04581629%5D&rft.jtitle=Bone%20Reports&rft.au=Gafni,%20Rachel&rft.date=2022-05&rft.volume=16&rft.spage=101558&rft.pages=101558-&rft.artnum=101558&rft.issn=2352-1872&rft.eissn=2352-1872&rft_id=info:doi/10.1016/j.bonr.2022.101558&rft_dat=%3Celsevier_cross%3ES2352187222003928%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1408-46538e7e8578afef291a6b203c3c2bceefe2e1e0d53bc981f74e5dfb98a6f2553%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true